BIOMAT Database Logo BIOMAT Database Logo

Carbocyclic analogues of nucleosides from bis-(Hydroxymethyl)-cyclopentane: synthesis, antiviral and cytostatic activities of adenosine, inosine and uridine analogues. 2003

José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, Spain. qojb@usc.es

Six new carbocyclic nucleosides were prepared by constructing a purine base (in compounds 9-11) or pyrimidine base (in 6-8) on the amino groups of (+/-)-(1 beta,2 alpha,4 beta)-4-amino-1,2-cyclopentanedimethanol (4) and (+/-)-(1 beta,3 alpha,4 beta)-4-amino-1,3-cyclopentanedimethanol (5), and their activities against a variety of viruses and tumour cell lines were determined.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D003517 Cyclopentanes A group of alicyclic hydrocarbons with the general formula R-C5H9. Cyclopentadiene,Cyclopentadienes,Cyclopentene,Cyclopentenes,Cyclopentane
D004267 DNA Viruses Viruses whose nucleic acid is DNA. DNA Virus,Virus, DNA,Viruses, DNA
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring. IV. Adenosine and uridine analogues.
January 2002, Nucleosides, nucleotides & nucleic acids,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Novel carbocyclic nucleosides containing a cyclopentyl ring. Adenosine and uridine analogues.
August 1997, Archiv der Pharmazie,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis and antiviral activities of carbocyclic oxetanocin analogues.
October 1990, Chemical & pharmaceutical bulletin,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Carbocyclic analogues of 5-substituted uracil nucleosides: synthesis and antiviral activity.
February 1983, Journal of medicinal chemistry,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Nucleotides and pronucleotides of 2,2-bis(hydroxymethyl)methylenecyclopropane analogues of purine nucleosides: synthesis and antiviral activity.
January 2005, Journal of medicinal chemistry,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis of (Z)-(2,3-bis-hydroxymethyl)methylenecyclopropane analogues of purine nucleosides.
March 2003, Nucleosides, nucleotides & nucleic acids,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis and antiviral activities of enantiomeric 1-[2-(hydroxymethyl) cyclopropyl] methyl nucleosides.
January 2000, Nucleosides, nucleotides & nucleic acids,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis and antiviral activities of 1,3-oxathiolanyl nucleosides with 5-hydroxymethyl substituent.
January 1999, Nucleosides & nucleotides,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Novel carbocyclic nucleosides containing a cyclobutyl ring: adenosine analogues.
September 2001, Chemical & pharmaceutical bulletin,
José Manuel Blanco, and Olga Caamaño, and Franco Fernández, and José Enrique Rodríguez-Borges, and Jan Balzarini, and Erik de Clercq
Synthesis of carbocyclic nucleosides as potential antiviral agents.
January 2001, Nucleic acids research. Supplement (2001),
Copied contents to your clipboard!